Brief: Abionyx Pharma End-Sept Cash And Cash Equivalents At Eur 3.2 Mln

Abionyx Pharma SA

04/11/2021 17:59

Nov 4 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 3.2 MILLION AT
SEPTEMBER 30, 2021
    * ANNOUNCED THAT IT HAS INITIATED DISCUSSIONS WITH IRIS
PHARMA
    * DISCUSSIONS WITH IRIS PHARMA CAN LEAD TO POSSIBLE
STRATEGIC DEAL
    * IRIS PHARMA'S CONTRACT RESEARCH ACTIVITY INTENDED TO
REMAIN
SEPARATE FROM THE BIOTECH ACTIVITY AND TO CONTINUE TO GROW

Source text for Eikon:  ID:nBw5xXJTXa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))